GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (OTCPK:HTSUF) » Definitions » Retained Earnings

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Retained Earnings : $1,621.3 Mil (As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Hisamitsu Pharmaceutical Co's retained earnings for the quarter that ended in Feb. 2024 was $1,621.3 Mil.

Hisamitsu Pharmaceutical Co's quarterly retained earnings declined from Aug. 2023 ($1,662.5 Mil) to Nov. 2023 ($1,610.8 Mil) but then increased from Nov. 2023 ($1,610.8 Mil) to Feb. 2024 ($1,621.3 Mil).

Hisamitsu Pharmaceutical Co's annual retained earnings declined from Feb. 2022 ($2,048.9 Mil) to Feb. 2023 ($1,770.6 Mil) and declined from Feb. 2023 ($1,770.6 Mil) to Feb. 2024 ($1,621.3 Mil).


Hisamitsu Pharmaceutical Co Retained Earnings Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Retained Earnings Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,098.79 2,214.67 2,048.92 1,770.58 1,621.35

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,770.58 1,724.39 1,662.53 1,610.78 1,621.35

Hisamitsu Pharmaceutical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Hisamitsu Pharmaceutical Co  (OTCPK:HTSUF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Headlines

No Headlines